{"schema_version":"1","generated_at":"2026-11-20T11:05:15.330Z","data_as_of":null,"url":"https://www.findmykol.com/kol/chad-deal","json_url":"https://www.findmykol.com/kol/chad-deal/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"chad-deal","name":"Chad Deal","credential":"MD","specialty":"Rheumatology","specialty_raw":"Rheumatology","therapeutic_area":"Rheumatology/Immunology","therapeutic_areas":["Rheumatology/Immunology"],"institution":"Cleveland Clinic","institution_url":"https://www.findmykol.com/institution/cleveland-clinic","city":"Cleveland","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"on_file":["npi","orcid","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Chad Deal is a Rheumatology/Immunology physician affiliated with Cleveland Clinic. OpenAlex indexes 94 publications with 6,607 citations (h-index 32); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Rheumatology/Immunology"]},"scholarship":{"works_count":94,"cited_by_count":6607,"h_index":32,"latest_activity_year":2025,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT00361595","title":"Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"The Cleveland Clinic","source_url":"https://clinicaltrials.gov/study/NCT00361595","trial_url":"https://www.findmykol.com/trial/NCT00361595"}],"source":"trials"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":22,"shown":3,"withheld":19,"rows":[{"payer":"Amgen Inc.","program_year":2025,"amount_usd":11976.93,"payment_count":19},{"payer":"Alexion Pharmaceuticals, Inc.","program_year":2025,"amount_usd":4315.59,"payment_count":3},{"payer":"Eli Lilly and Company","program_year":2025,"amount_usd":2875,"payment_count":1}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":10,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":25.5,"classes_total":5,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":9,"drugs":[{"name":"Tramadol Hcl","share_pct":86.4},{"name":"Oxycodone-Acetaminophen","share_pct":13.6}],"max_beneficiaries":null},{"class":"Nonsteroidal Anti-inflammatory Drug","setting":"prescribed","share_pct":8.1,"drugs":[{"name":"Meloxicam","share_pct":68.1},{"name":"Ibuprofen","share_pct":31.9}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":17.3,"classes_total":6,"classes":[{"class":"Folate Analog Metabolic Inhibitor","setting":"prescribed","share_pct":6.6,"drugs":[{"name":"Methotrexate","share_pct":91.1},{"name":"Methotrexate Sodium","share_pct":8.9}],"max_beneficiaries":null},{"class":"TNF inhibitor","setting":"prescribed","share_pct":4.5,"drugs":[{"name":"Humira Pen","share_pct":34.8},{"name":"Humira(Cf) Pen","share_pct":23.9},{"name":"Enbrel Sureclick","share_pct":15.2},{"name":"Simponi","share_pct":14.1},{"name":"Enbrel","share_pct":12}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":15.1,"classes_total":6,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":7.5,"drugs":[{"name":"Prednisone","share_pct":100}],"max_beneficiaries":57},{"class":"Tissue-nonspecific Alkaline Phosphatase","setting":"prescribed","share_pct":2.3,"drugs":[{"name":"Strensiq","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":83.8,"facility_pct":16.2},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults","year":2023,"journal":"Osteoporosis International","source_url":"https://doi.org/10.1007/s00198-023-06844-1","status":"verified"},{"title":"Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group","year":2023,"journal":"Osteoporosis International","source_url":"https://doi.org/10.1007/s00198-023-06843-2","status":"verified"},{"title":"The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature Surveillance","year":2023,"journal":"Osteoporosis International","source_url":"https://doi.org/10.1007/s00198-023-06859-8","status":"verified"},{"title":"Patient-reported experience with patient-reported outcome measures in adult patients seen in rheumatology clinics","year":2020,"journal":"Quality of Life Research","source_url":"https://doi.org/10.1007/s11136-020-02692-2","status":"verified"},{"title":"2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis","year":2018,"journal":"Arthritis & Rheumatology","source_url":"https://doi.org/10.1002/art.40726","status":"verified"}],"source":"works"},"similar":[{"name":"Steven Nissen","slug":"steven-nissen","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/steven-nissen","json_url":"https://www.findmykol.com/kol/steven-nissen/profile.json"},{"name":"Samir Kapadia","slug":"samir-kapadia","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/samir-kapadia","json_url":"https://www.findmykol.com/kol/samir-kapadia/profile.json"},{"name":"Mina Chung","slug":"mina-chung","institution":"Cleveland Clinic","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/mina-chung","json_url":"https://www.findmykol.com/kol/mina-chung/profile.json"},{"name":"Serpil Erzurum","slug":"serpil-erzurum","institution":"Cleveland Clinic","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/serpil-erzurum","json_url":"https://www.findmykol.com/kol/serpil-erzurum/profile.json"},{"name":"David Felson","slug":"david-felson","institution":"Boston University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/david-felson","json_url":"https://www.findmykol.com/kol/david-felson/profile.json"},{"name":"Marc Hochberg","slug":"marc-hochberg","institution":"University of Maryland School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/marc-hochberg","json_url":"https://www.findmykol.com/kol/marc-hochberg/profile.json"},{"name":"Philip Mease","slug":"philip-mease","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/philip-mease","json_url":"https://www.findmykol.com/kol/philip-mease/profile.json"},{"name":"Michelle Petri","slug":"michelle-petri","institution":"Johns Hopkins University School of Medicine","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/michelle-petri","json_url":"https://www.findmykol.com/kol/michelle-petri/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":19,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}